CAIN457G22101
The purpose of this study is to determine the PK, safety and tolerability of multiple doses of intravenous (i.v.) secukinumab in pediatric participants with JPsA
- Investigator
- Melissa E Elder
- Status
- Accepting Candidates
- Ages
- 2 Years - 17 Years
- Sexes
- All
HARBOR OLE
A Global Phase 3 Open-Label Extension Study to Assess the Long-Term Safety, Tolerability, and Efficacy of Intravenous Delpacibart Etedesiran (abbreviated del-desiran, formerly AOC
for the Treatment of Myotonic Dystrophy Type 1
- Investigator
- Sub Subramony
- Status
- Accepting Candidates
- Ages
- 16 Years - N/A
- Sexes
- All
DYNE-201 ACHIEVE
The primary purpose of the study is to evaluate the safety and tolerability of multiple intravenous (IV) doses of DYNE-101 administered to participants with Myotonic Dystrophy Type 1 (DM1).
The study consists of 4 periods: A Screening Period (up to…
- Investigator
- Sub Subramony
- Status
- Accepting Candidates
- Ages
- 18 Years - 65 Years
- Sexes
- All